BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 19246681)

  • 21. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction.
    Zaidi SH; Huang Q; Momen A; Riazi A; Husain M
    J Am Coll Cardiol; 2010 Jan; 55(2):135-43. PubMed ID: 20117381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB.
    Feng J; Lucchinetti E; Fischer G; Zhu M; Zaugg K; Schaub MC; Zaugg M
    Cardiovasc Res; 2008 Apr; 78(1):98-107. PubMed ID: 18218685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
    Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction.
    Pelzer T; Loza PA; Hu K; Bayer B; Dienesch C; Calvillo L; Couse JF; Korach KS; Neyses L; Ertl G
    Circulation; 2005 Mar; 111(12):1492-8. PubMed ID: 15781739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
    Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
    Ikeda S; Hamada M; Hiwada K
    Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.
    Ma D; Fu L; Shen J; Zhou P; Gao Y; Xie R; Li Y; Han Y; Wang Y; Wang F
    Eur J Pharmacol; 2009 Jan; 602(2-3):348-54. PubMed ID: 19027736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in cardiovascular function on treatment of inhibitors of apoptotic signal transduction pathways in left ventricular remodeling after myocardial infarction.
    Saitoh T; Nakajima T; Takahashi T; Kawahara K
    Cardiovasc Pathol; 2006; 15(3):130-8. PubMed ID: 16697925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart.
    Depre C; Wang L; Sui X; Qiu H; Hong C; Hedhli N; Ginion A; Shah A; Pelat M; Bertrand L; Wagner T; Gaussin V; Vatner SF
    Circ Res; 2006 Feb; 98(2):280-8. PubMed ID: 16373598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
    Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
    Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
    Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):178-87. PubMed ID: 18287886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for caspase-1 in heart failure.
    Merkle S; Frantz S; Schön MP; Bauersachs J; Buitrago M; Frost RJ; Schmitteckert EM; Lohse MJ; Engelhardt S
    Circ Res; 2007 Mar; 100(5):645-53. PubMed ID: 17303764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.